Attention to the role of prolyl 3-hydroxylation in collagen integrity was initially triggered by the discovery of CRTAP mutations as cause for OI, which was demonstrated by collagen overmodification (Morello et al. 2006). The gene discussed is CRTAP; the disease is osteogenesis imperfecta.